Compounds > efavirenz

efavirenz and Sleep Wake Disorders

efavirenz has been researched along with Sleep Wake Disorders in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (57.14)29.6817
2010's4 (28.57)24.3611
2020's2 (14.29)2.80

Authors

AuthorsStudies
Han, J; Li, B; Liu, Y; Xiao, J; Zhang, L; Zhao, H1
Bisaso, KR; Bisaso, KS; Ette, EI; Mukonzo, JK1
Castro, L; Chow, DC; Duerler, T; Gangcuangco, LMA; Kallianpur, KJ; Kohorn, L; Nagamine, L; Nakamoto, BK; Paul, R; Pien, FD; Shikuma, CM; Soll, B; Souza, S; Walker, M1
Chonzi, P; Dhoro, M; Kadzirange, G; Masimirembwa, C; Ngara, B; Nhachi, C; Zvada, S1
Gaida, R; Godman, B; Grobler, C; Kotze, T; Truter, I1
Felton-Coleman, A; Fletcher, CV; Owen, A; Podany, AT; Robertson, K; Sandkovsky, U; Swindells, S; Winchester, LC1
Gutiérrez-Valencia, A; López-Cortés, LF; Lozano, F; Palacios, R; Rivero, A; Ruiz-Valderas, R; Terrón, A; Viciana, P1
Delmas, B; Lochet, P; Lotthé, A; Mauboussin, JM; Peyrière, H; Reynes, J1
Barreiro, P; del Río, R; Gallego, L; González de Requena, D; González-Lahoz, J; Rodríguez-Albariño, A; Soriano, V1
Bharel, C; Koppel, BS1
Acosta, EP; Clifford, DB; Dorfman, D; Evans, S; Goodkin, K; Gulick, RM; Ribaudo, H; Simpson, D; Tashima, K; Yang, Y1
Delaporte, E; Girard, PM; Landman, R; Ndiaye, B; Ngom Gueye, NF; Poupard, M; Sow, PS; Thiam, D1

Reviews

1 review(s) available for efavirenz and Sleep Wake Disorders

ArticleYear
A review of trials investigating efavirenz-induced neuropsychiatric side effects and the implications.
    Expert review of anti-infective therapy, 2016, Volume: 14, Issue:4

    Topics: Alkynes; Anti-HIV Agents; Anxiety; Benzoxazines; Cyclopropanes; Depression; Dizziness; HIV Infections; Humans; Sleep Wake Disorders

2016

Trials

2 trial(s) available for efavirenz and Sleep Wake Disorders

ArticleYear
Stepped-dose versus full-dose efavirenz for HIV infection and neuropsychiatric adverse events: a randomized trial.
    Annals of internal medicine, 2009, Aug-04, Volume: 151, Issue:3

    Topics: Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Female; HIV Infections; Humans; Male; Mental Disorders; Middle Aged; Reverse Transcriptase Inhibitors; Sample Size; Sleep Wake Disorders; Viral Load

2009
Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals.
    Annals of internal medicine, 2005, Nov-15, Volume: 143, Issue:10

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Central Nervous System Diseases; Cyclopropanes; Female; HIV Infections; Humans; Male; Middle Aged; Mood Disorders; Oxazines; Prospective Studies; Reverse Transcriptase Inhibitors; Sleep Wake Disorders

2005

Other Studies

11 other study(ies) available for efavirenz and Sleep Wake Disorders

ArticleYear
Anxiety, depression, and sleep disturbances among people on long-term efavirenz-based treatment for HIV: a cross-sectional study in Beijing, China.
    BMC psychiatry, 2022, 11-16, Volume: 22, Issue:1

    Topics: Anxiety; Beijing; Cross-Sectional Studies; Depression; HIV Infections; Humans; Sleep; Sleep Wake Disorders

2022
Maximizing Knowledge Extraction From Patient-Reported Outcome Data Using Exposure-Outcome Item Response Modeling Approach: Understanding Efavirenz-Induced Central Nervous System Toxicity.
    Journal of clinical pharmacology, 2020, Volume: 60, Issue:6

    Topics: Alkynes; Benzoxazines; Central Nervous System; Cognitive Dysfunction; Computer Simulation; Cyclopropanes; Disease Progression; Drug Administration Schedule; Hallucinations; HIV Infections; Humans; Models, Psychological; Patient Reported Outcome Measures; Patient-Specific Modeling; Reverse Transcriptase Inhibitors; Severity of Illness Index; Sleep Wake Disorders; Symptom Assessment; Time Factors

2020
Sleep and neuropsychological performance in HIV+ subjects on efavirenz-based therapy and response to switch in therapy.
    HIV clinical trials, 2018, Volume: 19, Issue:4

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Central Nervous System Diseases; Cobicistat; Cyclopropanes; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Sleep Wake Disorders; Tenofovir

2018
CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe.
    BMC pharmacology & toxicology, 2015, Mar-27, Volume: 16

    Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Alleles; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B; Benzoxazines; Body Weight; Case-Control Studies; Cyclopropanes; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Drug Interactions; Female; Hallucinations; Headache; Humans; Male; Models, Biological; Rifampin; Sex Characteristics; Sleep Wake Disorders; Tuberculosis; Zimbabwe

2015
Impact of efavirenz pharmacokinetics and pharmacogenomics on neuropsychological performance in older HIV-infected patients.
    The Journal of antimicrobial chemotherapy, 2017, Volume: 72, Issue:1

    Topics: Aged; AIDS Dementia Complex; Alkynes; Anxiety; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Cytochrome P-450 CYP2B6; Depression; Female; HIV Infections; Humans; Male; Middle Aged; Neuropsychological Tests; Pharmacogenetics; Plasma; Polymorphism, Genetic; Reverse Transcriptase Inhibitors; Sleep Wake Disorders

2017
Comparison of side effects with 2 doses of the HIV drug efavirenz.
    Annals of internal medicine, 2009, Aug-04, Volume: 151, Issue:3

    Topics: Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Administration Schedule; Female; HIV Infections; Humans; Male; Mental Disorders; Middle Aged; Sample Size; Sleep Wake Disorders; Viral Load

2009
Long-term assessment of neuropsychiatric adverse reactions associated with efavirenz.
    HIV medicine, 2003, Volume: 4, Issue:1

    Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Anxiety Disorders; Benzoxazines; Cognition Disorders; Cyclopropanes; Depressive Disorder; Female; Follow-Up Studies; HIV Infections; Humans; Male; Mental Disorders; Middle Aged; Mood Disorders; Oxazines; Quality of Life; Sleep Wake Disorders; Surveys and Questionnaires

2003
Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Feb-01, Volume: 38, Issue:3

    Topics: Adult; Alkynes; Benzoxazines; Cyclopropanes; Electroencephalography; Female; HIV Infections; Humans; Male; Oxazines; Reverse Transcriptase Inhibitors; Sleep Initiation and Maintenance Disorders; Sleep Stages; Sleep Wake Disorders

2004
Use of amitriptyline to offset sleep disturbances caused by efavirenz.
    AIDS patient care and STDs, 2005, Volume: 19, Issue:7

    Topics: Alkynes; Amitriptyline; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; Humans; Male; Middle Aged; Oxazines; Risk Assessment; Sleep Wake Disorders; Treatment Outcome

2005
Summaries for patients. Neuropsychological side effects of efavirenz.
    Annals of internal medicine, 2005, Nov-15, Volume: 143, Issue:10

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Central Nervous System Diseases; Cyclopropanes; Female; HIV Infections; Humans; Male; Middle Aged; Mood Disorders; Oxazines; Prospective Studies; Reverse Transcriptase Inhibitors; Sleep Wake Disorders

2005
Quality of life and depression among HIV-infected patients receiving efavirenz- or protease inhibitor-based therapy in Senegal.
    HIV medicine, 2007, Volume: 8, Issue:2

    Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Depression; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Quality of Life; Senegal; Sex Distribution; Sleep Wake Disorders

2007